Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT00939744
Other study ID # 09-040
Secondary ID
Status Recruiting
Phase N/A
First received July 14, 2009
Last updated March 3, 2015
Start date May 2009
Est. completion date October 2015

Study information

Verified date March 2015
Source Université de Sherbrooke
Contact Stéphanie Corriveau, BSc
Phone 819 346-1110
Email stephanie.corriveau@usherbrooke.ca
Is FDA regulated No
Health authority Canada: Ethics Review Committee
Study type Observational

Clinical Trial Summary

Recent studies show that EET and 20-HETE have important biological effects, particularly in the vascular system. The investigators studied the effect of eicosanoids on the gravid rat uterus. The results suggest that 20-HETE had an tocolytics effect on gravid uterus. In the previous study, we demonstrated that the enzymes of the pathway of EET were present in human uterine tissues. Moreover, the addition of an inhibitor of degradation of EET had an tocolytic effect on the human myometrium, as the exogenous addition of 8.9, 14,15-EET and 20-HETE.

Objectives:

Primary objective: To compare the balance of different metabolic pathways of arachidonic acid (AA) of the pregnant human myometrium in pathological situations (preterm labor, uterine atony, prolonged pregnancy).

Specific objectives: i) To study the effect of derived from the AA on in vitro contractile activity of normal and pathological uterine tissues, and ii) detect and quantify the different sub-products of metabolism of AA in the uterine tissues (myometrium, fetal membranes and placenta).

The management of uterine contraction is in the heart of modern obstetrics year, yet the progress made in other specialties, based on the study of smooth muscle have not yet been transposed in obstetrics. A better understanding of systems for regulating the contraction is important in terms of 1) new physiological knowledge, but it could also be the source of 2) modification of strategies to take care of premature delivery (new Tocolytic), or 3) improving the efficiency of uterine muscle during delivery or 4) for treatment of patients with prolonged pregnancy.


Description:

It is a clinical study with a slope fundamental aims to examine the metabolic pathways of AA of human myometrium and their functional roles according to their clinical profile divided into three contractile pathological situations - threat of premature delivery, dynamic dystocia, prolonged pregnancy - and two groups of patients at term: a group before work and group work.

The sampling method. After birth, a biopsy will be perform from the lower segment of the uterus. After caesarean sections of membrane and placenta are collected.

The substances studied during isometric tension tests are part of the three degradation pathways of the AA.

1. new eicosanoids in cumulative dose (8,9-EET, 11,12-EET, 14,15-EET, 20-HETE), and in combination

2. enzyme inhibitors of the eicosanoids pathway (AUDA, MS-PPOH, DDMS), and the COX and LOX pathways (indomethacin), alone or in combination.


Recruitment information / eligibility

Status Recruiting
Enrollment 130
Est. completion date October 2015
Est. primary completion date July 2015
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- all women who will have a c-section

Exclusion Criteria:

- induction of labor,

- child with malformation,

- birth weight less than 2500 grams or greater than 4500g

Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Locations

Country Name City State
Canada Centre hospitalier de l'Université de Sherbrooke Sherbrooke Quebec

Sponsors (2)

Lead Sponsor Collaborator
Université de Sherbrooke Fonds de la Recherche en Santé du Québec

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary effect of eicosanoids on contractile activity of myometrium of pregnant women with pathological situations during c-section No
Secondary effect of enzymatic inhibitors on contractile activity of myometrium from pregnant women with pathological situations during c-section No
Secondary detection of enzymes from the different pathways after c-section No
Secondary quantification of eicosanoids in different tissues after c-section No
See also
  Status Clinical Trial Phase
Recruiting NCT04481503 - Transthoracic Echocardiography of Ventricular Function of Parturients in Labor
Terminated NCT02899481 - Role of Intrapartum Ultrasound in Instrumental Delivery N/A
Completed NCT00787241 - Platelet Count Trends in Pre-eclamptic Parturients N/A
Terminated NCT04163679 - Vaginal Preparation and Azithromycin to Reduce Post Cesarean Infections N/A
Suspended NCT02326077 - Sonopartogram. The Next Step in the Delivery Room
Completed NCT02318420 - The PartoMa Project: For Improving Monitoring, Action and Triage During Labour N/A
Not yet recruiting NCT05763043 - Monoferric for Prenatal Iron Deficiency Early Phase 1
Not yet recruiting NCT06131684 - Amniotic Fluid Analysis Early Phase 1
Completed NCT03922087 - No-worry Baby Project
Completed NCT03341351 - Use of the Modified Beef Tongue Model for Teaching Repair of Obstetrical Fourth-Degree Laceration to Residents N/A
Completed NCT02834897 - Performance Evaluation of System EOS Imaging in Pelvimetry Versus Pelvi-scanner N/A
Recruiting NCT03830879 - Shenzhen Birth Cohort Study
Recruiting NCT01930721 - Comparison of Incision Angle of Mediolateral Episiotomy at 40 and 60 Degrees Phase 2
Enrolling by invitation NCT03387189 - Evaluation of a Quality Improvement Project on Impacted Fetal Head at Cesarean Section
Completed NCT04253197 - Ultrasound Staging in the Placenta Accreta N/A
Completed NCT04494529 - Single Dose Antenatal Corticosteroids (SNACS) for Women at Risk of Preterm Birth Phase 3
Recruiting NCT05264779 - The Periviable GOALS Decision Support Tool N/A
Active, not recruiting NCT03944512 - Pravastatin to Prevent Preeclampsia Phase 3
Recruiting NCT05313256 - Quick Epidural Top-up With Alkalinized Lidocaine for Emergent Caesarean Delivery Phase 2/Phase 3
Completed NCT02461251 - Thromboelastometry-guided Treatment Protocol Versus Standard Care of Major Haemorrhage in Obstetric Patients N/A